Aesthetic pathway
Skin Renewal
GHK-Cu
Laboratory verification
Nothing unverified is published
Every compound is prepared to a documented standard. Independent certificates of analysis are published here per batch as they are verified under Nuragen's own governance, we do not reuse another brand's certificates or purity figures.
Certificate of analysis · per batch · on request
Verification-led release
Skin Renewal is a research-use-only preparation of GHK-Cu, a naturally-occurring copper-binding tripeptide. It is studied within the aesthetic pathway for its role in collagen synthesis and tissue remodelling.
How it is studied
GHK-Cu is a well-characterised copper peptide that appears widely across the research literature. In laboratory and preclinical settings it has been investigated for how it signals within extracellular matrix processes, particularly collagen and elastin synthesis and the turnover of skin tissue. Studies describe it as a modulator of gene expression associated with wound-related and remodelling pathways, which is why it remains a recurring subject of dermatological and biochemical research. NURAGEN supplies this material for that research context only.
What the component is and the pathway it acts on
The single component is GHK-Cu, a tripeptide of glycine, histidine and lysine bound to a copper(II) ion. This copper-binding structure is thought to underlie much of its studied activity, since the peptide is understood to help shuttle copper in ways relevant to matrix biology. Within the aesthetic pathway it is researched for how it acts on fibroblast signalling and the synthesis of structural proteins such as collagen. The descriptions here are of mechanism and pathway, not of any effect a person would experience.
How it sits in a responsible research programme
Skin Renewal is positioned as a defined single-compound input for controlled laboratory work, where a known peptide identity supports reproducible study design. It is not offered for human or animal use, and no dosing, protocol or administration guidance is provided. A responsible programme documents handling, storage and chain of custody, and interprets any observation against the published literature rather than against expectation. This is the accountable footing on which the compound is made available.
Composition
| Component | CAS | Purity |
|---|---|---|
| GHK-Cu | 49557-75-7 | Pending |
| Type | Lyophilised powder |
|---|---|
| Presentation | Lyophilised powder |
| Appearance | White lyophilised powder |
| Storage | Store at 2-8°C, protected from light. |
| Dispatch | Delivered within 72 hours across the UK. |
Handling should follow standard laboratory practice and your own institutional protocols. No dosing, administration or medical guidance is provided.
GHK-Cu is a naturally-occurring copper-binding tripeptide studied in collagen synthesis and tissue remodelling. This material is supplied strictly for research use only. It is not a medicine, supplement or cosmetic, and it is not intended for human or animal use.
As with many peptides, it is generally handled cold and kept refrigerated at 2-8C and protected from light, with exposure to heat, moisture and repeated temperature changes minimised. Handling should follow your own laboratory's standard operating procedures. We describe general storage practice only and do not provide protocols for use.
No. We provide the compound identity and factual, research-oriented information about the pathways GHK-Cu is studied to act on. We do not provide dosing, administration, treatment or medical advice of any kind. Any research use is designed and overseen by the qualified researcher.
In the research literature GHK-Cu is frequently examined for how it signals within the extracellular matrix, including processes linked to collagen and elastin. Because these are structural proteins of skin, studies of the peptide are often grouped under the aesthetic pathway. This reflects the mechanisms it is researched to act on, not an outcome for any individual.
In context
Evidence before action
GHK-Cu has an unusually deep research record for a small peptide, yet a body of literature is a starting point for enquiry, not a shortcut around it. Reading the primary studies, noting the model system each used, and distinguishing observed mechanism from inferred benefit are what keep interpretation honest. We describe what the compound is understood to do within research, and leave conclusions to the work itself. That is what 'science, made accountable' means in practice.


